Overview
Key stats
Fundamentals Sep 10- Open
- $517.00
- 52-wk high
- $769.98
- High
- $522.49
- 52-wk low
- $511.16
- Low
- $511.16
- Prev close
- $520.21
- Mkt cap
- $40.58B
- P/E
- 36.5x
- Volume
- 556.5K
- Fwd P/E
- 31.4x
- Beta
- 1.54
- P/S
- 8.9x
- P/B
- 25.4x
- Profit margin
- +25.0%
- Op margin
- +35.0%
- ROE
- +74.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 8.1% above what analysts expected.
Earnings per share
$3.95 expected
GAAP EPS was $4.27 and adjusted EPS was $4.07. The analyst basis could not be confirmed, so no beat or miss is shown.
Reports Nov 2, 2026, in 53 days
EPS expected
$3.37 to $3.91
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.11B | $1.09B | $1.14B | $1.22B |
| Cost of what it sold | $421.9M | $432.5M | $418.1M | $437.5M |
| Gross profit | $683.4M | $658.1M | $722.7M | $779.1M |
| What it spent | ||||
| Research and development | $63.4M | $66.8M | $65.8M | $65.4M |
| Sales and admin | $105.9M | $108.6M | $119.1M | $116.8M |
| Other operating costs | $159.2M | $167.1M | $175.3M | $171.3M |
| Total operating expenses | $328.5M | $342.5M | $360.2M | $353.5M |
| What was left | ||||
| Operating profit | $354.8M | $315.6M | $362.6M | $425.6M |
| Interest on debt | $10.7M | $10.5M | $7.7M | $10.2M |
| Profit before tax | $344.8M | $307.0M | $355.4M | $417.2M |
| Tax | $70.2M | $58.8M | $77.0M | $78.8M |
| Net profit | $274.6M | $248.2M | $278.4M | $338.4M |
| EBITDA | $392.1M | $356.2M | $400.9M | $468.5M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Idexx Laboratories stock hits 52-week low at $517.00
NeutralSep 9IDEXX Laboratories stock heads into the open after a modest gain
Leans bullishSep 9IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors
BearishSep 8ETFs Investing in IDEXX Laboratories, Inc. Stocks
NeutralSep 6Precipio Inc (NASDAQ: PRPO) Share Price, PRPO Stock News, PRPO Share Price & Updates
NeutralSep 5IDEXX Laboratories Inc. stock outperforms competitors on strong trading day
BullishSep 4Resilient IDEXX Laboratories stock holds above $550 as earnings beat supports guidance
NeutralSep 1IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Leans bullishAug 31
Macro
32 macro signals shaping IDXX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results